PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
04-Jun-2021 Exelixis Announces Consistent Efficacy Benefits Across Subgroups of Phase 3 CheckMate -9ER Trial of CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) as a First-line Treatment for Patients with Advanced Renal Cell Carcinoma Businesswire
04-Jun-2021 Magenta Therapeutics Announces Additional Preliminary Positive Results from Ongoing Phase 2 Clinical Trial of MGTA-145 and Plerixafor in Patients with Multiple Myeloma at the American Society of Clinical Oncology (ASCO) Annual Meeting Businesswire
04-Jun-2021 Exelixis Announces Quality-Adjusted Survival Benefit Demonstrated in Analysis of Phase 3 CheckMate -9ER Trial of CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) in Patients with Previously Untreated Advanced Renal Cell Carcinoma Businesswire
04-Jun-2021 BeiGene Presents Clinical Data from Two Phase 2 Trials of Pamiparib at the 2021 ASCO Annual Meeting Businesswire
04-Jun-2021 BeiGene Presents Clinical Data from Two Pivotal Trials of Tislelizumab at the 2021 ASCO Annual Meeting Businesswire
04-Jun-2021 Lyvgen Biopharma Presents Clinical Trial Data of CD137/4-1BB Agonistic Antibody LVGN6051 at the 2021 ASCO Annual Meeting Businesswire
04-Jun-2021 Exelixis Announces Positive Phase 2 Results for CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma at ASCO 2021 Businesswire
04-Jun-2021 Global Psychedelic Drugs Market Research Report 2021: Analysis by Drug, Route of Administration, Distribution Channel, Pipeline Drugs and Forecast to 2026 - ResearchAndMarkets.com Businesswire
04-Jun-2021 POINT Biopharma Announces First Patients Dosed in Phase 3 Study of PNT2002 for mCRPC Businesswire
04-Jun-2021 Analytical Laboratory Instrument Global Market Report 2021: COVID-19 Impact and Recovery to 2030 - ResearchAndMarkets.com Businesswire
04-Jun-2021 SQZ Biotechnologies Initial First-In-Human Data Demonstrates Investigational Cell Therapy is Safe and Can Stimulate Immune Responses in Certain Patients with Advanced or Metastatic HPV16+ Tumors Businesswire
04-Jun-2021 Genentech Presents Latest Advances With Immunotherapies in Non-Hodgkin’s Lymphoma Businesswire
04-Jun-2021 Worldwide Irritable Bowel Syndrome (IBS) Diagnostics Industry to 2028 - Increasing Disposable Incomes Present Opportunities - ResearchAndMarkets.com Businesswire
04-Jun-2021 Global Hydrolyzed Collagen Market to 2027 - COVID-19 Impact and Analysis - ResearchAndMarkets.com Businesswire
04-Jun-2021 Virios Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating IMC-1 in Patients with Fibromyalgia Businesswire
04-Jun-2021 Precision BioSciences Reports Progress on Two Strategies Designed to Optimize Durability of Allogeneic CAR T Therapy in R/R Non-Hodgkin Lymphoma Businesswire
04-Jun-2021 GRAIL Presents Interventional PATHFINDER Study Data at 2021 ASCO Annual Meeting and Introduces Galleri, a Groundbreaking Multi-Cancer Early Detection Blood Test Businesswire
04-Jun-2021 Ribon Therapeutics Announces Oral Presentation of Positive Interim Data from Phase 1 Trial of RBN-2397 in Patients with Advanced Solid Tumors at 2021 ASCO Annual Meeting Businesswire
04-Jun-2021 4D pharma Completes Enrollment of Part A of the Phase I/II Trial of MRx-4DP0004 for the Treatment of Asthma and Provides Program Update Businesswire
04-Jun-2021 Boston Properties Builds on Its Growing Life Sciences Portfolio, Acquires Lab Properties in Waltham, Massachusetts Businesswire